COPANLISIB for Colorectal cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where COPANLISIB was used for Colorectal cancer.
Most Reported Side Effects for COPANLISIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 58 | 16.3% | 10 | 53 |
| Off label use | 43 | 12.1% | 1 | 20 |
| Hyperglycaemia | 27 | 7.6% | 2 | 18 |
| Hypertension | 24 | 6.8% | 1 | 12 |
| Rash maculo-papular | 24 | 6.8% | 4 | 16 |
| Pneumonia | 20 | 5.6% | 6 | 15 |
| Sepsis | 19 | 5.4% | 8 | 12 |
| Diarrhoea | 18 | 5.1% | 2 | 5 |
| Rash | 16 | 4.5% | 3 | 10 |
| Febrile neutropenia | 15 | 4.2% | 6 | 8 |
| Neutropenia | 15 | 4.2% | 3 | 5 |
| Neutropenic sepsis | 15 | 4.2% | 2 | 14 |
| Anaemia | 14 | 3.9% | 4 | 12 |
| Dyspnoea | 14 | 3.9% | 6 | 12 |
| Cytopenia | 13 | 3.7% | 0 | 11 |
Other Indications for COPANLISIB
Follicular lymphoma (42)
B-cell lymphoma (38)
Marginal zone lymphoma (29)
Product used for unknown indication (23)
Non-hodgkin's lymphoma recurrent (20)
Diffuse large b-cell lymphoma (17)
Non-hodgkin's lymphoma (11)
B-cell lymphoma recurrent (10)
Diffuse large b-cell lymphoma recurrent (10)
Non-hodgkin's lymphoma unspecified histology indolent (6)
Other Drugs Used for Colorectal cancer
OXALIPLATIN (2,951)
BEVACIZUMAB (2,788)
FLUOROURACIL (2,440)
CAPECITABINE (1,686)
LEUCOVORIN (1,478)
IRINOTECAN (1,446)
REGORAFENIB (1,313)
CETUXIMAB (909)
PANITUMUMAB (878)
TIPIRACIL\TRIFLURIDINE (404)